Highlander Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Highlander Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$12.7K	Hold	140	–	–	﹤0.01%	654
2023 Q4	$11.4K	Hold	140	–	–	﹤0.01%	682
2023 Q3	$11K	Hold	140	–	–	﹤0.01%	640
2023 Q2	$11K	Hold	140	–	–	0.01%	514
2023 Q1	$11K	Hold	140	–	–	0.01%	499
2022 Q4	$11K	Hold	140	–	–	0.01%	473
2022 Q3	$9K	Hold	140	–	–	0.01%	483
2022 Q2	$11K	Hold	140	–	–	0.01%	465
2022 Q1	$11K	Hold	140	–	–	0.01%	471
2021 Q4	$11K	Hold	140	–	–	0.01%	461
2021 Q3	$10K	Hold	140	–	–	0.01%	463
2021 Q2	$10K	Hold	140	–	–	0.01%	483
2021 Q1	$10K	Hold	140	–	–	0.01%	484
2020 Q4	$9K	Hold	140	–	–	0.01%	503
2020 Q3	$9K	Hold	140	–	–	0.01%	494
2020 Q2	$9K	Hold	140	–	–	0.01%	494
2020 Q1	$8K	Hold	140	–	–	0.01%	510
2019 Q4	$9K	Hold	140	–	–	0.01%	527
2019 Q3	$8K	Sell	140 -500	-78%	-$28.6K	﹤0.01%	555
2019 Q2	$38K	Hold	640	–	–	0.02%	357
2019 Q1	$39K	Sell	640 -100	-14%	-$5.91K	0.02%	359
2018 Q4	$41K	Hold	740	–	–	0.03%	336
2018 Q3	$48K	Hold	740	–	–	0.03%	363
2018 Q2	$44K	Hold	740	–	–	0.02%	375
2018 Q1	$41K	Hold	740	–	–	0.02%	382
2017 Q4	$44K	Hold	740	–	–	0.03%	371
2017 Q3	$43K	Sell	740 -350	-32%	-$19.9K	0.03%	379
2017 Q2	$64K	Hold	1,090	–	–	0.05%	306
2017 Q1	$60K	Hold	1,090	–	–	0.05%	311
2016 Q4	$57K	Hold	1,090	–	–	0.05%	308
2016 Q3	$63K	Hold	1,090	–	–	0.06%	308
2016 Q2	$64K	Sell	1,090 -650	-37%	-$37.9K	0.06%	314
2016 Q1	$100K	Sell	1,740 -400	-19%	-$23.7K	0.09%	244
2015 Q4	$140K	Buy	2,140 +200	+10%	+$12.9K	0.13%	189
2015 Q3	$122K	Buy	1,940 +1,000	+106%	+$70.3K	0.12%	209
2015 Q2	$67K	Hold	940	–	–	0.06%	317
2015 Q1	$66K	Hold	940	–	–	0.06%	327
2014 Q4	$60K	Hold	940	–	–	0.05%	344
2014 Q3	$59.8K	Buy	940 +40	+4%	+$2.48K	0.06%	311
2014 Q2	$55.8K	Buy	900 +400	+80%	+$23.8K	0.05%	316
2014 Q1	$29.2K	Hold	500	–	–	0.03%	446
2013 Q4	$26.6K	Hold	500	–	–	0.03%	456
2013 Q3	$23.9K	Hold	500	–	–	0.02%	480
2013 Q2	$22.7K	Buy	+500	New	+$23.1K	0.02%	482

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Highlander Capital Management's PPH Position: Q1 2024 in Review

Highlander Capital Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2024 at 140 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Highlander Capital Management first reported a position in PPH in Q2 2013 and has held it in 44 quarters since. The position peaked at $140K in Q4 2015. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

Highlander Capital Management held 140 shares of VanEck Pharmaceutical ETF worth $12.7K as of Q1 2024.
Highlander Capital Management left its VanEck Pharmaceutical ETF share count unchanged in Q1 2024.
VanEck Pharmaceutical ETF made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #654 holding.
Highlander Capital Management first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 44 quarters since.
Highlander Capital Management's VanEck Pharmaceutical ETF position peaked at $140K in Q4 2015.
138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.